Cargando…
The combination of quantitative faecal occult blood test and faecal calprotectin is a cost-effective strategy to avoid colonoscopies in symptomatic patients without relevant pathology
BACKGROUND: Faecal occult blood test (FOBT) has demonstrated effectiveness in colorectal cancer (CRC) screening. Faecal calprotectin (FC) has proven efficient for evaluating activity in inflammatory bowel disease (IBD), but its value in CRC detection is less established. Most symptomatic patients ha...
Autores principales: | Lué, Alberto, Hijos, Gonzalo, Sostres, Carlos, Perales, Alba, Navarro, Mercedes, Barra, Maria Victoria, Mascialino, Barbara, Andalucia, Carmen, Puente, Juan José, Lanas, Ángel, Gomollon, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7235671/ https://www.ncbi.nlm.nih.gov/pubmed/32523623 http://dx.doi.org/10.1177/1756284820920786 |
Ejemplares similares
-
A Point-of-Care Faecal Test Combining Four Biomarkers Allows Avoidance of Normal Colonoscopies and Prioritizes Symptomatic Patients with a High Risk of Colorectal Cancer
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2023) -
A Patient Self-Made Point-of-Care Fecal Test Improves Diagnostic Accuracy Compared with Fecal Calprotectin Alone in Inflammatory Bowel Disease Patients
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
Reducing the Cut-Off Value of the Fecal Immunochemical Test for Symptomatic Patients Does Not Improve Diagnostic Performance
por: Navarro, Mercedes, et al.
Publicado: (2020) -
The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort
por: Hijos-Mallada, Gonzalo, et al.
Publicado: (2021) -
Fecal occult blood and calprotectin testing to prioritize primary care patients for colonoscopy referral: The advantage study
por: Lanas, Ángel, et al.
Publicado: (2023)